Activated prothrombin complex concentrate for dabigatran-associated bleeding

被引：38

作者：

Schulman, Sam ^{[1
]}

Ritchie, Bruce ^{[2
]}

Goy, Jennifer K. ^{[1
]}

Nahirniak, Susan ^{[3
]}

Almutawa, Mohammad ^{[4
]}

Ghanny, Shari ^{[1
]}

机构：

[1] McMaster Univ, Dept Med, Hamilton, ON, Canada

[2] Univ Alberta, Dept Med, Edmonton, AB, Canada

[3] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada

[4] Univ Alberta, Mazankowski Heart Inst, Div Cardiol, Edmonton, AB, Canada

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 164卷 / 02期

关键词：

dabigatran; bleeding activated prothrombin complex concentrate; DIRECT THROMBIN INHIBITOR; TIME;

D O I：

10.1111/bjh.12620

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：308 / 310

页数：3

共 10 条

[1] Acutely Injured Patients on Dabigatran [J].

Cotton, Bryan A. ;

McCarthy, James J. ;

Holcomb, John B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (21) :2039-2040

[2] Reversing Dabigatran in Life-Threatening Bleeding Occurring During Cardiac Ablation With Factor Eight Inhibitor Bypassing Activity [J].

Dager, William E. ;

Gosselin, Robert C. ;

Roberts, A. Josh .

CRITICAL CARE MEDICINE, 2013, 41 (05) :E42-E46

[3] Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits [J].

Elg, M ;

Carlsson, S ;

Gustafsson, D .

THROMBOSIS RESEARCH, 2001, 101 (03) :159-170

[4] Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor [J].

Elg, M ;

Carlsson, S ;

Gustafsson, D .

THROMBOSIS RESEARCH, 2001, 101 (03) :145-157

[5] Mechanisms and monitoring of bypassing agent therapy [J].

Hoffman, M. ;

Dargaud, Y. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) :1478-1485

[6] Effective elimination of dabigatran by haemodialysis A phase I single-centre study in patients with end-stage renal disease [J].

Khadzhynov, Dmytro ;

Wagner, Frank ;

Formella, Stephan ;

Wiegert, Erol ;

Moschetti, Viktoria ;

Slowinski, Torsten ;

Neumayer, Hans-H. ;

Liesenfeld, Karl-Heinz ;

Lehr, Thorsten ;

Haertter, Sebastian ;

Friedman, Jeffrey ;

Peters, Harm ;

Clemens, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) :596-605

[7] Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation [J].

Louet, Agnes Lillo-Le ;

Wolf, Martine ;

Soufir, Lilia ;

Galbois, Arnaud ;

Dumenil, Anne-Sylvie ;

Offenstadt, Georges ;

Samama, Meyer-Michel .

THROMBOSIS AND HAEMOSTASIS, 2012, 108 (03) :583-585

[8] Bleeding and antidotes in new oral anticoagulants [J].

Majeed, Ammar ;

Schulman, Sam .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) :191-202

[9] A specific antidote for dabigatran: functional and structural characterization [J].

Schiele, Felix ;

van Ryn, Joanne ;

Canada, Keith ;

Newsome, Corey ;

Sepulveda, Eliud ;

Park, John ;

Nar, Herbert ;

Litzenburger, Tobias .

BLOOD, 2013, 121 (18) :3554-3562

[10] The Successful Reversal of Dabigatran-Induced Bleeding by Coagulation Factor Concentrates in a Rat Tail Bleeding Model Do Not Correlate with Ex Vivo Markers of Anticoagulation [J].

van Ryn, Joanne ;

Schurer, Johanna ;

Kink-Eiband, Monika ;

Clemens, Andreas .

BLOOD, 2011, 118 (21) :1004-1004

← 1 →